Benefits of Group Psychotherapy Programs in the Treatment of Obesity
Benefits of a Psychotherapy Group Program as Oppossed to the Standard Method in the Treatment of Obesity. A Randomized Controlled Trial.
1 other identifier
interventional
180
1 country
1
Brief Summary
Obesity has reached pandemic proportions in recent years, affecting not only the physical health, but also the mental health, of obese people. According to Spain's National Health Survey 2011-12, the prevalence of obesity in the adult population of Spain was 17%, having increased by 2.5% since 2006. Therefore, a constant and worrying increase in the prevalence of obesity is being observed, which is having a great impact, both individually, in terms of health and quality of life, and socially, inter alia, by raising health expenditure due to increased morbidity. In this context, the desirability of a comprehensive approach that includes psychological intervention in attending obese patients (Rev Cochrane, 2006), has been given greater prominence. Paying attention to the emotional and psychopathological aspects related to obesity has proven to be an action that could have positive impact on obesity intervention models. The aim of this project is to measure, through a clinical trial, the efficacy of a psychotherapy group program for obesity patients who are attended by the consulting endocrinologist at the Infanta Leonor Hospital (Madrid). The impact of body mass index, psychological wellbeing, psychopathology and quality of life of two experimental study groups will be compared, one a control group of patients that follows the standard treatment, the other an experimental group that follows not only the standard treatment, but also the psychotherapy group intervention program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Jan 2017
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 30, 2019
CompletedFirst Posted
Study publicly available on registry
May 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedOctober 19, 2022
October 1, 2022
3 years
April 30, 2019
October 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
weight difference
Difference between the initial and final weight in kilograms
1 year
Secondary Outcomes (8)
Global Severity Index (GSI)
1 year
Positive Symptom Distress Index (PSDI)
1 year
Positive Symptom Total (PST).
1 year
Eating disorder risk (EDRC)
1 Year
Physical quality of life
1 year
- +3 more secondary outcomes
Study Arms (3)
Control
NO INTERVENTIONStandard treatment at Hospital Infanta Leonor with Endocrinology and Psyquiatry
Completers
EXPERIMENTALRandomized to treatment AND complete treatment 14 sessions are needed
Drop-out
NO INTERVENTIONRandomized to treatment BUT do not assist or do not complete treatment Less than 14 sessions
Interventions
Added to standard treatment patients will participate in a standardized group of psychological intervention. 21 sessions with 10 to 12 members closed-ended groups.
Eligibility Criteria
You may qualify if:
- Age older than 18 and younger than 65.
- Body mass index of 30 or higher.
- Candidate to a specific obesity treatment.
- Accept psychological attention.
- Able to understand and consent participation.
- Able to speak, write and read in Spanish.
- Committed to assist weekly for 6 months
- Obesity related to a non- stabilized hormonal disorder.
- Severe mental disorders requiring specific treatment resources.
- Cognitive or sensitive deficits.
- Having had bariatric surgery within last 2 years.
You may not qualify if:
- Pregnancy during treatment
- Bariatric surgery during treatment
- Addictive disorder as a principal diagnosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Universitario Infanta Leonorlead
- Carlos III Health Institutecollaborator
Study Sites (1)
Hospital Universitario Infanta Leonor
Madrid, 28031, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miriam Félix, PhD
Study Principal Investigator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Psychiatry Department Head
Study Record Dates
First Submitted
April 30, 2019
First Posted
May 3, 2019
Study Start
January 1, 2017
Primary Completion
December 31, 2019
Study Completion
June 30, 2020
Last Updated
October 19, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share